RPS6 and Parkinson disease: WB analysis confirmed the significant increase in the levels of p-mTOR and its downstream effectors; p-RPS6 and the phosphorylated eukaryotic initiation factor 4E-binding protein 1 (4EBP1) in PD NPCs as compared to control cells (Figure 5B).